PMDA drug package insert
アキャルックス点滴静注250mg
PMDA Prescription drug · 楽天メディカル株式会社 · package insert Oct 9, 2024
Key facts
| Brand names | アキャルックス点滴静注250mg |
|---|---|
| Nonproprietary names | セツキシマブ サロタロカンナトリウム（遺伝子組換え） |
| Companies | 製造発売元／楽天メディカル株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 抗体-光感受性物質複合体 |
| Therapeutic category codes | 874299 |
| YJ codes | 4299406A1020 |
| Approval numbers | 30200AMX00942000 |
| Package insert edition | 第8版 |
| Package insert date | Oct 9, 2024 |
| PMDA document key | 841001_4299406A1020_1 |
| PMDA company code | 841001 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: